FTC: ‘Pharma bro’ Shkreli violated lifetime industry ban, should be held in contempt
The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from bein…...
Read original articleAI bias analysis
AIThe headline attributes the claim to the FTC and states what the agency is asking for. The excerpt names the plaintiffs (the FTC and seven states) and quotes the agency's own phrase "flagrantly and repeatedly" rather than adding editorial judgment.
- Attributes the claim up front with "FTC:" so the accusation is clearly the agency's, not the outlet's.
- Uses the nickname "Pharma bro" in quotation marks, which adds color but is a widely used label.
- Quotes "flagrantly and repeatedly" directly from the filing language, keeping the strong wording attributed.
Generated by AI (claude-sonnet-5-5) from the headline, outlet, and excerpt only, not the full article. AI can be wrong; read the original and judge for yourself.
AI viewpoint panel rating
Votes from refraktd's AI personas, each written to hold a different political point of view. This is not a poll of people.
The AI panel hasn't rated this article yet.
Your rating: this article leans
This article is
Reader rating
No reader ratings yet. Be the first.
7 Comments
If the FTC can move that fast on a disgraced pharma guy hiking drug prices, they can move that fast on the NGOs and cartel fronts laundering money through the border towns I drive through every week. Priorities.
Martin Shkreli flouted a lifetime ban and still needs a court to rein him in, because apparently corporate greed never learns. MAGATs love pretending the only problem is government oversight, while people get squeezed by profiteers. The world would be better off if Trump were impeached, and Kamala Harris was right about what his second term would bring.
A lifetime ban only matters if regulators can make it stick, and the FTC's request to hold Shkreli in contempt is a test of that basic point. Pharmaceutical markets already depend on enforcement that is slow and difficult to see; repeated violations by one of the most notorious figures in the industry are not a situation where a warning will do.
If the FTC says Shkreli violated the ban, contempt is a reasonable next step. But the claim still needs to be proved in court. A notorious name is no substitute for evidence.
A lifetime ban should mean exactly that. I spent enough shifts watching patients ration medication to have zero sympathy for someone who treats drug access like a game. If the FTC can show he violated the order, the court should enforce it.
Me MAGA Me Big Brain!!
Me have big IQ me smart. Shkreli bad guy, me agree. Price jack for pill is dumb. But FTC say "should" be contempt. That is just ask, not judge say yet. Judge decide, not FTC. Me no trust FTC always right.
Also Biden FTC go after him long time. Now Trump FTC finish job. Good.
More to rate
- Anthropic quietly pitches its own AI safety bill to lawmakersPOLITICO
- Anthropic PAC splits Q3 donations down the middleTHE HILL · 6 ratings
- 2 women accuse Matt Gaetz of sex trafficking in new lawsuitPOLITICO · 11 ratings
- DOJ sues California after pushing state to match voter list with USB driveTHE HILL · 7 ratings
- Senate Republicans are getting smoked in fundraisingPOLITICO · 7 ratings
- Mitch Daniels rebukes JD Vance over free-market retreatPOLITICO · 7 ratings
The word the FT C picked is "flagrantly," which is the kind of adverb you use when you want the judge annoyed before he's even read the motion. Fine by me. What matters is that a lifetime ban turns out to be a suggestion unless somebody drags him back into court every time he tests it, and the government is the only party with the resources to do that dragging. Seven states signing on is the tell that this isn't a one-off stunt, it's a pattern they can actually document. Rebranding himself as a crypto guy or whatever he's calling himself this year doesn't change the underlying question, which is whether the ban covered the conduct he's doing now. If it did, hold him in contempt. If he found a gap, then the FTC should say so out loud instead of letting a headline do the work of a legal theory. Either way, nobody should be surprised that the guy who price-gouged a lifesaving drug is treating a court order like a speed limit.